ATProto Browser
Experimental browser for the Atmosphere
Experimental browser for the Atmosphere
9. People with hemophilia often need regular infusions to prevent bleeding. But now, a long-acting treatment has been approved. In March, the FDA approved Qfitlia, an under-the-skin shot given once every 2 months. It cut bleeding episodes by 70% in trials compared to standard treatment.
May 2, 2025, 4:20 PM
{
"uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5y6e3f26",
"cid": "bafyreia4lzmaqzolkdtlemavrjgodr5qlu4pfbvs7me2teyhwxcco5zfbu",
"value": {
"text": "9. People with hemophilia often need regular infusions to prevent bleeding. But now, a long-acting treatment has been approved.\n\nIn March, the FDA approved Qfitlia, an under-the-skin shot given once every 2 months. It cut bleeding episodes by 70% in trials compared to standard treatment.",
"$type": "app.bsky.feed.post",
"langs": [
"en"
],
"reply": {
"root": {
"cid": "bafyreif27i7xp4g2yyuhdaucmmhi2vrvk46xkgfeysxkych72qpth2fomu",
"uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5vtuc226"
},
"parent": {
"cid": "bafyreihosf72qvcvwobrmi2cdm6u6ipdjpisbstvwbwwzdw2yfx22dp4xi",
"uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5y6e3e26"
}
},
"createdAt": "2025-05-02T16:20:35.881Z"
}
}